600781 Stock Overview
FUREN Group Pharmaceutical Co., Ltd. primarily engages in the manufacture and distribution of pharmaceuticals in Henan Province and Shanghai, China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
FUREN Group Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥0.77 |
| 52 Week High | CN¥3.65 |
| 52 Week Low | CN¥0.51 |
| Beta | 0.61 |
| 1 Month Change | -8.33% |
| 3 Month Change | -34.19% |
| 1 Year Change | n/a |
| 3 Year Change | -79.30% |
| 5 Year Change | -95.02% |
| Change since IPO | -66.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600781 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0% | 3.3% | -0.3% |
| 1Y | n/a | -14.4% | -14.6% |
Return vs Industry: Insufficient data to determine how 600781 performed against the CN Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 600781 performed against the CN Market.
Price Volatility
| 600781 volatility | |
|---|---|
| 600781 Average Weekly Movement | 16.5% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 600781's share price has been volatile over the past 3 months.
Volatility Over Time: 600781's weekly volatility has increased from 10% to 17% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 2,916 | n/a | www.shfuren.cn |
FUREN Group Pharmaceutical Co., Ltd. primarily engages in the manufacture and distribution of pharmaceuticals in Henan Province and Shanghai, China. The company produces traditional Chinese medicines, such as capsules, tablets, granules, injections, eye drops, oral liquids, cream, and others. The company was formerly known Shanghai Minfeng Industrial (Group) Co., Ltd.
FUREN Group Pharmaceutical Co.,Ltd. Fundamentals Summary
| 600781 fundamental statistics | |
|---|---|
| Market cap | CN¥482.91m |
| Earnings (TTM) | -CN¥2.75b |
| Revenue (TTM) | CN¥1.58b |
0.3x
P/S Ratio-0.2x
P/E RatioIs 600781 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600781 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.58b |
| Cost of Revenue | CN¥783.59m |
| Gross Profit | CN¥798.23m |
| Other Expenses | CN¥3.55b |
| Earnings | -CN¥2.75b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.39 |
| Gross Margin | 50.46% |
| Net Profit Margin | -174.14% |
| Debt/Equity Ratio | -144.8% |
How did 600781 perform over the long term?
See historical performance and comparison